ANDA 206234, held by Invagen Pharms. Sevelamer Carbonate.
As of Nov 16, 2026, ANDA 206234 (Sevelamer Carbonate), held by Invagen Pharms, was first approved by FDA on Jul 12, 2024, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 12, 2024 | Original application | Approved | None posted |
| Sevelamer Carbonate800MG/PACKET · for suspension;oral | Sevelamer Carbonate | Discontinued |
| Sevelamer Carbonate2.4GM/PACKET · for suspension;oral | Sevelamer Carbonate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters